Hopfner Robert Lorne Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
10
Insider Buys Sum
$26.68M
Insider Sells Quantity
21
Insider Sells Sum
$42.73M

Insider Activity of Hopfner Robert Lorne

Biography of Hopfner Robert Lorne

No biography is available at this moment.

2021-08-02PurchaseRallybio Corporation
RLYB
director
576,923
1.5136%
$13.00$7.5M-39.61%
2021-02-10SaleVaxcyte, Inc.
PCVX
director
156,316
0.3024%
$26.53$4.15M-14.96%
2021-02-09SaleVaxcyte, Inc.
PCVX
director
441,488
0.8718%
$28.19$12.45M-18.32%
2021-02-08SaleVaxcyte, Inc.
PCVX
director
159,592
0.3087%
$25.79$4.12M-12.2%
2021-02-03SaleVaxcyte, Inc.
PCVX
director
5,536
0.0112%
$25.06$138,732-4.97%
2021-02-02SaleVaxcyte, Inc.
PCVX
director
28,468
0.0559%
$25.13$715,401-8.16%
2021-01-28SaleVaxcyte, Inc.
PCVX
director
4,000
0.0081%
$25.07$100,280-4.68%
2021-01-27SaleVaxcyte, Inc.
PCVX
director
4,280
0.0086%
$25.30$108,284-6.27%
2021-01-26SaleVaxcyte, Inc.
PCVX
director
36,284
0.0726%
$25.30$917,917-6.59%
2021-01-25SaleVaxcyte, Inc.
PCVX
director
69,944
0.1353%
$25.81$1.81M-11.35%
2021-01-22SaleVaxcyte, Inc.
PCVX
director
22,766
0.0445%
$25.16$572,793-7.78%
2021-01-21SaleVaxcyte, Inc.
PCVX
director
200
0.0004%
$25.11$5,022-1.94%
2021-01-20SaleVaxcyte, Inc.
PCVX
director
38,092
0.0764%
$25.35$965,632-5.91%
2021-01-19SaleVaxcyte, Inc.
PCVX
director
99,032
0.0963%
$12.81$1.27M-9.63%
2021-01-15SaleVaxcyte, Inc.
PCVX
director
53,354
0.1046%
$25.78$1.38M-9.2%
2021-01-14SaleVaxcyte, Inc.
PCVX
director
29,836
0.0584%
$25.88$772,156-9.45%
2021-01-13SaleVaxcyte, Inc.
PCVX
director
58,220
0.1082%
$24.54$1.43M-9.3%
2021-01-12SaleVaxcyte, Inc.
PCVX
director
37,134
0.0736%
$26.38$979,742-10.03%
2021-01-11SaleVaxcyte, Inc.
PCVX
director
99,332
0.1914%
$26.45$2.63M-12.71%
2021-01-08SaleVaxcyte, Inc.
PCVX
director
81,224
0.161%
$26.58$2.16M-10.63%
Total: 23
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.